University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, 60637, United States
NCT Number: NCT00000252
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine the lack of acute tolerance development to the subjective, cognitive, and psychomotor effects of nitrous oxide in healthy volunteers.
Looking for future studies?
Notify Me21 year–29 year
All sexes
Interventional
Phase 2
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Please contact site for information.
Time frame: During inhalation
Subjects will undergo psychomotor testing during 120 min inhalation session of each intervention
Time frame: During inhalation
Subjects will under cognitive testing during 120 minute inhalation session of each intervention
University of Chicago
Other
Lack of Acute Tolerance Development to Effects of Nitrous Oxide
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00000250
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00000255
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00000262
Agnosia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT06023459
Chemically-Induced Disorders, Mental Disorders
El Dorado, Arkansas, United States
View Trial Details